TinT10: Long Term Follow up of the Titanium Modular Revision Hip System, With Review of Metal Ion Levels

Sponsor
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06033651
Collaborator
(none)
100
14

Study Details

Study Description

Brief Summary

Patients are to be approached to attend clinic who have been identified as being implanted with either a Lima Corporate Delta Revision TT, Delta One TT or the Delta Multihole Systems hip systems between 2011 and 2013, a minimum of 10 years since hip surgery. They will be x-rayed (AP pelvis and a lateral view) and a blood test will be taken and sent to a lab in Surrey to check titanium levels.

Condition or Disease Intervention/Treatment Phase
  • Radiation: x-ray

Detailed Description

Since its popularisation in the 1960's, Hip replacements have become one of the NHS's highest volume procedures. Unfortunately, hip replacements can fail with on average 8,500 revision hip replacements being performed each year pre-covid. Often this is very complex with destruction of the normal anatomy leaving surgeons with a significant challenge in ensuring appropriate positioning of the socket within the confines of the patient's anatomy.

The Lima Corporate Delta Revision TT, Delta One TT and Delta Multihole Systems are designed to help surgeons with this very problem by providing the option of a 'face changer' allowing surgeons to place a socket within a socket.

To allow for this function, the 'face changer' must connect with the acetabular cup (socket). Through research, it is widely known that when metals interact within the body, they can cause wear and shedding of metal debris. This process is known as metallosis and can result in metal ions being released into the surrounding bone and tissues as well as being absorbed into the blood stream.

The risk of this is highest when there is significant movement between the components (such as in metal-on-metal hip replacements). It is less of an issue at other interfaces which are not intended to allow movement between them. That said, our hypothesis is that the increase in the number of interfaces which gives us the flexibility we need, may increase the release of free metal ions in the blood stream. The aim of this study is to therefore identify if this is in fact the case and if so, whether the increase in ions is sufficient for surgeons to bear in mind.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Long Term Follow up of the Titanium Modular Revision Hip System, With Review of Metal Ion Levels
Anticipated Study Start Date :
Sep 30, 2023
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Nov 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Only 1 arm for the study

All participants shall receive the same treatment.

Radiation: x-ray
A sample of blood will be taken and sent to a lab in Surrey to check for metal ions.
Other Names:
  • blood sample
  • Outcome Measures

    Primary Outcome Measures

    1. The survivourship of the modular acetabular hip system at 10 years post-op [Once blood results are back from the specialist assessment laboratory (approximately 3 weeks post clinic visit).]

      By looking at titanium ion blood levels and pelvis x-rays, this gives an indication of whether the device is loosening and failing in this particular hip system.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    All adult patients who had Lima Corporate modular titanium acetabular component implants implanted between 2012 and 2013.

    Exclusion Criteria:

    Deceased patients Patients who have undergone a subsequent acetabular revision Patients that lack capacity Prisoners in the custody of HM Prison service or who are offenders supervised by the probation service in England or Wales.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

    Investigators

    • Principal Investigator: Robin Banerjee, The Robert Jones and Agnes Hunt Orthopaedic Hospital Foundation Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
    ClinicalTrials.gov Identifier:
    NCT06033651
    Other Study ID Numbers:
    • version 1 27/6/2023
    First Posted:
    Sep 13, 2023
    Last Update Posted:
    Sep 13, 2023
    Last Verified:
    Sep 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Sep 13, 2023